Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor documentation/version update that doesn't change the study details.
    Difference
    0.1%
    Check dated 2026-07-28T05:19:24.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision tag updates from v3.6.2 to v3.6.3, indicating a minor update to the page. This does not alter the study information presented.
    Difference
    0.1%
    Check dated 2026-07-06T15:52:09.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 on the page. This reflects a minor software update to the ClinicalTrials.gov interface rather than a change to the study details presented.
    Difference
    0.1%
    Check dated 2026-06-29T08:51:02.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Recruitment status is updated to no longer looking for participants, reflecting that the study is not enrolling anymore. There are also new navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—and a formatting update of the Intervention/Treatment label with a Revision: v3.6.0 badge.
    Difference
    0.4%
    Check dated 2026-06-15T05:53:49.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    A new revision tag v3.5.5 appears on the page, replacing the previous v3.5.4, indicating an administrative update to the page template rather than a change to study data.
    Difference
    0.1%
    Check dated 2026-06-08T03:59:24.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    The page shows an updated revision tag from v3.5.3 to v3.5.4, indicating a new build or patch. This appears to be maintenance-related and does not alter study content or data presented on the page.
    Difference
    0.1%
    Check dated 2026-05-17T09:15:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.